Navigation Links
Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
Date:1/4/2012

THOUSAND OAKS, Calif., Jan. 4, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 30th Annual J.P. Morgan Global Healthcare Conference at 10:00 a.m. Pacific Time on Monday, Jan. 9, 2012, at the Westin St. Francis in San Francisco, Calif.  Robert A. Bradway, president and chief operating officer at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com.  Follow us on www.twitter.com/amgen.

 

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)

(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)

 

 

 

 


'/>"/>
SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
2. Amgen Announces 2012 First Quarter Dividend
3. Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)
4. Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy
5. Amgen’s Third Quarter 2011 Revenue and Adjusted Earnings Per Share (EPS) Each Increased 3 Percent to $3.9 Billion and $1.40
6. Amgen Appoints Anthony (Tony) Hooper Executive Vice President Global Commercial Operations
7. Amgen Appoints Robert A. Bradway to the Companys Board of Directors
8. Amgen Announces 2011 Fourth Quarter Dividend
9. Amgen to Present at the UBS Global Life Sciences Conference
10. Amgen Staff Volunteer Efforts Result in $5,000 For Each of Their Favorite Nonprofits
11. Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures(TM) Educational Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2019)... ... May 21, 2019 , ... DuPont Nutrition ... opened the inaugural Africa Brewing Conference dedicated to sharing brewing knowledge, strengthening relationships ... event, which is supported through a partnership with “Ethiopia Invest”, will run through ...
(Date:5/14/2019)... TOWNSHIP, N.J. (PRWEB) , ... May 13, 2019 ... ... of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device ... new Heliumleak.com company website. The redesigned website aims to improve LDA’s ability to ...
(Date:5/7/2019)... ... May 06, 2019 , ... "The new Liquid Nitrogen Best ... being asked to store cellular products being used in adoptive therapy research ... world leaders, who have shared their expertise in building and managing facilities to ...
(Date:5/2/2019)... ... April 30, 2019 , ... ... Standardization ISO 9001:2015 standard, REPROCELL USA Inc. has demonstrated its ability to ... REPROCELL USA Inc. aims to enhance customer satisfaction through the effective implementation ...
Breaking Biology Technology:
(Date:7/17/2019)... ... July 16, 2019 , ... Imagine using a simple, portable test to ... before it causes osteoporosis. For South Dakota School of Mines & Technology researcher Congzhou ... in terms of our ability to monitor and prevent disease,” says Wang. , ...
(Date:7/9/2019)... Del. (PRWEB) , ... July 08, 2019 , ... ... Court ruled in favor of Danisco’s ownership of the innovation behind two Danisco ... that an entitlement action could be based on prior art was without merit ...
(Date:6/20/2019)... , ... June 19, 2019 , ... ... by the Infectious Diseases Society of America Foundation, and the possibly millions of ... to study infectious agents in AD, are a “welcome affirmation” of the need ...
Breaking Biology News(10 mins):